Regurgitation, infantile colic and functional constipation are common functional gastrointestinal disorders (FGIDs) during infancy. Approximately 30% of infants suffer from regurgitation and about 3 in 4 infants with regurgitation also experience other gastrointestinal (GI) symptoms.
The results of this study, assessing the safety and tolerance of a novel anti-regurgitation formula, show that the test AR formula with LBG, postbiotics and prebiotics is well-tolerated and safe to use in infants with regurgitation. In addition, there was a significant reduction of regurgitation within the first week for both AR formulas as well as a significant improvement of overall GI burden and most GI symptoms (e.g. stooling, crying, gassiness and fussiness) within the first week, with further improvement over time.